Maravai LifeSciences Q3 2024 Earnings Call Transcript
MRVI Stock | USD 1.98 0.09 4.35% |
Under 61% of Maravai Lifesciences' investor base is looking to short. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that many investors are alarmed at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
MRVI earnings call for the period ending September 30, 2024.
Read at fool.com
![]() |
Maravai Lifesciences Fundamental Analysis
We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Maravai Lifesciences is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Maravai Lifesciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.
Peers
Maravai Lifesciences Related Equities
ALEC | Alector | 12.50 | ||||
ARQT | Arcutis Biotherapeutics | 0.07 | ||||
HRMY | Harmony Biosciences | 0.12 | ||||
DNLI | Denali Therapeutics | 0.42 | ||||
LEGN | Legend Biotech | 0.81 | ||||
EWTX | Edgewise Therapeutics | 0.82 | ||||
INSM | Insmed | 0.84 | ||||
INCY | Incyte | 1.26 | ||||
FOLD | Amicus Therapeutics | 1.64 | ||||
IMVT | Immunovant | 1.96 | ||||
PTGX | Protagonist Therapeutics | 2.16 | ||||
CYTK | Cytokinetics | 2.40 | ||||
RARE | Ultragenyx | 2.42 | ||||
AGIO | Agios Pharm | 2.57 | ||||
HALO | Halozyme Therapeutics | 2.75 | ||||
APLS | Apellis Pharmaceuticals | 2.86 | ||||
ARGX | Argenx NV | 3.42 | ||||
ROIV | Roivant Sciences | 3.54 | ||||
KRYS | Krystal Biotech | 3.64 | ||||
ASND | Ascendis Pharma | 5.11 | ||||
AKRO | Akero Therapeutics | 5.99 |
Complementary Tools for Maravai Stock analysis
When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |